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Abstract 1 
Background: Pre-clinical research on the neuroprotective effect of hypothermia after perinatal 2 
asphyxia has shown variable results, depending on co-morbidities and insult severity. 3 
Exposure to inflammation increases vulnerability of the neonatal brain to hypoxic-ischaemic 4 
(HI) injury, and could be one explanation for those neonates whose injury is unexpectedly 5 
severe. Gram-negative type inflammatory pre-sensitisation with lipopolysaccharide (LPS) prior 6 
to a mild HI insult negates hypothermic neuroprotection. However, the neuroprotective effect 7 
of HT is fully maintained after gram-positive type pre-sensitisation with PAM3CSK4 (PAM) in 8 
the same HI model. Whether HT is neuroprotective in severe brain injury with gram-positive 9 
inflammatory pre-sensitisation has not been investigated. 10 
Methods: 59 seven-day-old rat pups were subjected to a unilateral HI insult, with left carotid 11 
artery ligation followed by 90 min hypoxia (8% O2 at Trectal 36°C). An additional 196 pups 12 
received intraperitoneal 0.9% saline (control) or PAM1mg/kg, 8 h before undergoing the same HI 13 
insult. After randomisation to 5 h normothermia (NT37°C) or HT32°C, pups survived one week 14 
before they were sacrificed by perfusion fixation. Brains were harvested for hemispheric (HEM) 15 
and hippocampal (HIP) area loss analyses at P14, as well as immunostaining for neuron count 16 
in the HIP CA1 region. 17 
Results: Normothermic PAM animals (PAM-NT) had a comparable median area loss (HEM: 18 
60% (95% CI 33-66); HIP: 61% (95% CI 29-67)) to vehicle animals (Veh-NT) (HEM: 58% (95% 19 
CI 11-64); HIP: 60% (95% CI 19-68)), which is defined as severe brain injury. Furthermore, 20 
mortality was low and similar in the two groups (Veh-NT 4.5% vs PAM-NT 6.6%). HT 21 
significantly reduced HEM and HIP injury in the Veh group (HEM: p=0.048; HIP: p=0.042) as 22 
well as in the PAM group (HEM: p=0.03; HIP: p=0.027).  23 
Conclusion: In these experiments with severe brain injury, TLR-2 exposure prior to HI does 24 
not have an additive injurious effect, and there is a small but significant neuroprotective effect 25 
of HT. Hypothermia appears to be neuroprotective over a continuum of injury severity in this 26 
 3 
model, and the effect size tapers off with increasing area loss. Our results indicate that gram-1 
positive inflammatory exposure prior to HI injury does not negate a neuroprotective effect of 2 
HT in severe brain injury.  3 
 4 
Introduction 1 
 2 
Perinatal hypoxic-ischaemic (HI) brain injury remains a major cause of long-term neurological 3 
disability and death in term newborns [1]. For term neonates with moderate and severe HI 4 
encephalopathy (HIE), hypothermia (HT) treatment is standard of care, and it is currently the 5 
only approved treatment option [2]. With a number needed to treat of 8, 45-50% of 6 
encephalopathic term babies will still die or suffer from long-term disability despite HT therapy 7 
[3]. However, in follow-up studies from large randomized clinical trials, infants with the most 8 
severe HIE had the most severe neurological dysfunction, and have been hypothetised to 9 
benefit less from HT [3]. Pre-clinical studies of hypothermic neuroprotection after severe HI 10 
brain injury have shown conflicting results [4–6].  11 
Perinatal infection is a wellrecognised risk factor for cerebral palsy (CP) and long-term disability 12 
[7–9]. Systemic inflammation lowers the threshold at which an HI insult leads to permanent 13 
neuronal injury [10–12]. In a study well before HT was introduced, Grether and Nelson 14 
identified maternal pyrexia or chorioamnionitis during birth in 37% of patients who developed 15 
the most severe form of cerebral palsy, compared to only in 3% in the general population [8]. 16 
In animal models of inflammation the toll-like receptor (TLR)-2 agonist PAM3CSK4 (PAM) 17 
induces inflammatory activation which mimics gram-positive infection [13] – the most 18 
frequently-isolated group of pathogens in term neonates with early onset sepsis (EOS) [14]. 19 
However, as it is cheap, readily available and easy to work with, the most commonly-used 20 
inflammatory trigger in experimental research is E. coli lipopolysaccharide (LPS). LPS only 21 
represents gram-negative type infections, and PAM and LPS act differently as inflammatory 22 
activators. A systemic injection of either PAM or LPS prior to a mild unilateral HI insult in the 23 
neonatal rat both sensitises the immature brain and increases injury severity [15–18]. However, 24 
as opposed to after LPS sensitised HI brain injury, HT is still highly neuroprotective in PAM-25 
sensitised injury (previous data combined in Fig. 1) [17]. 26 
 5 
Whether HT is neuroprotective in the setting of a more severe inflammation-sensitised HI brain 1 
injury is unknown. We therefore aimed to investigate HT neuroprotective effect in a model of 2 
more severe brain injury, both with and without inflammatory pre-sensitisation, in the postnatal 3 
day 7 (P7) neonatal rat. 4 
 5 
 6 
Figure 1. Hemispheric area loss (%) after pre-sensitisation and a mild HI insult. 7 
Horizontal lines represent the median. Bars show median with 95% confidence interval. The 8 
graph compares left hemispheric area loss (%) after pre-sensitisation with lipopolysaccharide 9 
(LPS) or PAM3CSK4 (PAM), carotid artery ligation and 50 min hypoxia (8%O2 at 36°C). Pups 10 
were randomised to 5 hours normothermia treatment (NT37°C) or hypothermia treatment 11 
(HT32°C). LPS NT: n=18; LPS HT: n=24; PAM NT: n=36; PAM HT: n=32. Mortality per group 12 
(%) is inserted above. HT provided significant neuroprotection after 1 week’s survival in PAM-13 
sensitised pups (p<0.0002), but not in LPS-sensitised pups. Modified and combined from 14 
Osredkar et al and Falck et al [16,17]. 15 
16 
 6 
Material and Methods 1 
Animals and injections 2 
All experiments were approved by the University of Oslo's Animal Ethics Research 3 
Committee. Experiments were performed on 7-day-old (P7) Wistar rats (Charles River 4 
Laboratories, Sulzfeld, Germany) of both genders. Litters were culled to 10 pups. All pups 5 
were kept in an animal facility with a 12:12-hr dark/light cycle at 21°C environmental 6 
temperature with food and water ad libitum. Animals were randomised across litter, sex and 7 
weight before the experiments commenced.  8 
To trigger inflammation we used the synthetically-manufactured TLR-2/1 agonist 9 
PAM3CSK4 (PAM3CSK4 Vaccigrade, Sigma-Aldrich) (PAM) in a dose of 1 mg/kg, dissolved in 10 
sterile LPS-free water, further diluted in 0.9% NaCl. The dose of PAM was based on previous 11 
publications on neonatal rodents [13,19,20], in combination with our own dose-response 12 
experiments where we compared post-insult hemispheric area loss according to our standard 13 
protocol [17]. We titrated the dose in combination with 50 minutes (min) of 8% hypoxia in order 14 
to produce what we have previously defined as a moderate degree of brain injury (around 40% 15 
area loss of the affected hemisphere), as we have done previously in the LPS-sensitised model 16 
[16]. Fig. 1 compares previously published data on LPS- and PAM-sensitised HI brain injury. 17 
Control groups received a single dose of vehicle (sterile physiological 0.9% NaCl) (Veh). All 18 
injections were given intraperitoneally in a volume of 10µl/g body weight.  19 
In this model, PAM is injected 8 hours (h) prior to carotid artery ligation (compared to 4 h in the 20 
LPS model). This time-point was based on the post-injection temporal development of 21 
intracerebral inflammatory cytokines from a previous study [21]. IL-6 and TNF-α peaked 2 h 22 
after an LPS injection, whereas after an injection of PAM, IL-6 and TNF-α were significantly 23 
upregulated after 6 h, indicating a more delayed intracerebral inflammatory activation. A 24 
subsequent pilot experiment with different pre-sensitisation times made us chose an 8 h 25 
incubation period between injection and commencement of surgical procedures (Fig. 2).  26 
 7 
 1 
 2 
Figure 2. Different pre-insult sensitisation time.  3 
Inflammatory pre-sensitisation with PAM3CSK4 (PAM) was induced 4, 8 or 24 hours (h) prior 4 
to the hypoxic-iscaemic insult (n=10-11/group). Error bars show 95% CI of hemispheric area 5 
loss (%) after carotid artery ligation and 50 min hypoxia (8%O2 at 36°C). Veh 4 h: Vehicle 6 
injected 4 h prior to the insult. PAM 4 h, PAM 8 h and PAM 24 h: PAM injected 4, 8 or 24 h 7 
respectively, prior to the insult.  8 
 9 
Surgical Procedures and HI 10 
Comparing results from different experimental laboratories are challenging due to variations in 11 
the methods used. In our laboratory we have administered the insult with three different 12 
severity levels, depending on the aim of the study. When inflammatory pre-sensitisation is 13 
added to the model, the injury is more severe, and the “mild insult” will result in a moderate 14 
injury (table 1).  15 
 16 
 17 
 8 
 
Hypoxic insult: 
 
50 min 8% O2  
@ 36ºC 
 
90 min 8% O2  
@ 36ºC 
 
150 min 8% O2  
@ 37ºC 
 
Injury degree without 
pre-sensitisation / 
Veh groups 
 
 
Mild injury: 
< 20% area loss 
 
Moderate injury: 
~ 40% area loss 
 
Severe injury: 
~ 60% area loss 
Injury degree with 
inflammatory  
pre-sensitisation 
(LPS or PAM) 
 
Moderate injury: 
~ 40% area loss 
 
Severe injury: 
~ 60% area loss 
 
 1 
Table 1. Relationship between insult severity and degree of injury.  2 
The table shows the median degree of injury we have seen traditionally in our lab after a 3 
mild, moderate or severe hypoxic-ischaemic insult. First row shows the standard model, the 4 
second row shows how the degree of injury changes with inflammatory pre-sensitisation.  5 
 6 
However, the injury induced is not always in line with the insult severity, due to a variable 7 
vulnerability in the rat pups. Various factors might explain the well-known variability in the 8 
Vannucci model, and some have attributed it to a variability in communicational blood flow [22]. 9 
We have seen an increased vulnerability in the pups after the 2005 changes in EU-regulation 10 
for animal transport were enforced from 2015. The amendments have led to rat pups being 11 
cross-fostered to a dam which is not biologically theirs [23]. 12 
Therefore, to re-characterise the model as run in our laboratory, we first performed a series of 13 
two-group experiments without inflammatory pre-sensitisation. We used the experimental 14 
protocol planned for the current study, namely unilateral (left) carotid artery ligation followed 15 
by 90 min 8% O2 at Trectal 36°C (Fig. 3). 16 
All surgical procedures were performed as previously described [17], but followed by a 90 min 17 
instead of a 50 min hypoxic insult. Briefly, at the start of each experiment, animals were injected 18 
with PAM or Veh according to randomisation. After an 8 h delay with their dams, pups 19 
underwent ligation of the left carotid artery under isoflurane anaesthesia followed by exposure 20 
 9 
to 8% O2 for 90 min at Trectal 36.0°C, which without PAM exposure results in moderate brain 1 
injury in this model (table 1) [4]. Immediately thereafter, pups received either of the two 2 
allocated treatments: 5h of normothermia (NT); Trectal 37.0°C or hypothermia (HT); Trectal 32.0°C. 3 
During treatment, the core and surface temperature of two ‘sentinel' pups from the Veh groups, 4 
were continuously recorded in each chamber. Rectal temperature was maintained within 5 
±0.2°C of the target value using a continuous temperature recording (IT-21; Physitemp 6 
Instruments, Clifton, N.J., USA), which servo-controlled a water-filled mat (CritiCool, MTRE, 7 
Yavne, Israel) on the floor of the chamber. After the 5 h treatment period, pups were returned 8 
to their dams.  9 
 10 
Figure 3. Model variability; Hemispheric area loss (%) after 50 or 90 minutes of 11 
hypoxia.  12 
The floating bars show median area loss with 95% confidence interval from a series of 13 
experiments with different hypoxia times (the first two: 50 min, the next three: 90 min), 14 
producing a mild and moderate injury, respectively, with a degree of injury along a 15 
spectrum of severity. The red bars display normothermia (NT) treated groups, and the 16 
blue bars display hypothermia (HT) treated groups in the corresponding experiments. 17 
The HT-mediated reduction in median injury degree (%) per experiment is indicated by 18 
the numbers in squares. 19 
 10 
 1 
Histopathology and Area loss analyses 2 
Pups were sacrificed at P14 by trans-cardiac perfusion-fixation with 10% neutral-buffered 3 
formalin under isoflurane-N2O-anaesthesia. Brains were harvested and kept in 10% 4 
neutral-buffered formalin until further processing. Coronal blocks (3 mm) were cut using a 5 
standard rat matrix (ASI instruments Inc., Warren, MI, USA), and embedded in paraffin. 6 
Slices (5 µm) were cut from the two neighbouring blocks best representing cortex, 7 
hippocampus, basal ganglia and thalamus. Sections were stained with hematoxylin and 8 
eosin (H&E) and scanned (Epson Perfection V750 Pro). Virtual slides were exported with 9 
600 dpi resolution. Optical density and hemispheric area was analysed using ImageJ 10 
computer software (ImageJ, version 1.46r, National Institutes of Health, Bethesda, MD, 11 
USA). The ligated side was compared to the non-ligated side, and area loss of the ligated 12 
side calculated by the formula (1 – (area left/area right))*100. Percent hemispheric area 13 
loss has previously been shown to correlate well with a formal 9-graded step neuropathology 14 
score in this model [4]. 15 
Evaluation of hippocampal area loss was performed in the same way, and calculated as: 16 
(1 − (area of left hippocampus/area of right hippocampus))*100. A subset of the H&E stained 17 
sections were examined for hemispheric and hippocampal areas by two blinded assessors to 18 
check for inter-rater reliability. 19 
 20 
Immunohistochemistry 21 
Immunohistochemical staining was performed as described in previous publications using 22 
the same material and antibodies [17].  Briefly, slides were prepared from paraffin-23 
embedded sections. Primary mouse antibody against NeuN (1:500; Millipore), was applied 24 
overnight at 4°C. In control brain sections, the primary antibodies were omitted. Secondary 25 
Alexa Fluor 568 (Invitrogen, 1:500) antibodies stayed on for 1 h at room temperature. 26 
 11 
Finally, the slides were coverslipped with ProLong Gold with DAPI (Invitrogen). Sections 1 
were scanned (Axio Scan.Z1; Carl Zeiss, Jena, Germany) using the fluorescence mode 2 
with plan apochromatic 20X lens, and exported as high-resolution tiff images for further 3 
analysis. 4 
The hippocampus is known to be particularly vulnerable to hypoxia [24–26]. Therefore, to 5 
evaluate the effect of different treatments on hippocampal neuronal loss, NeuN and DAPI-6 
positive cells in the CA1 region of the hippocampus were counted. Aiming for a 7 
representative subset from each treatment group, the 10 animals closest to the median 8 
hemispheric area loss, were selected for formal hippocampal neuron counting, as in previous 9 
publications [5]. Three non-overlapping fields, each sized 200 μm x 200 μm, of the CA1 10 
region in the left hippocampi were assessed. Counting was performed by two individual 11 
observers blinded to the treatment groups, and an average of the two was taken. The total 12 
number of neurons across the three fields of each hippocampus was summed and 13 
compared across groups. 14 
 15 
Statistical Data Analysis 16 
Statistical analyses were performed using GraphPad Prism version 6 (GraphPad Software Inc., 17 
La Jolla, Ca, USA) and SPSS software version 22 (SPSS Inc., Chicago, IL, USA). As the data 18 
are not normally distributed, non-parametric statistics were applied. The Kruskal-Wallis test 19 
was used for comparisons across multiple treatment groups, and the Wilcoxon-Mann-Whitney 20 
test was used for two-group comparisons to get two-tailed p-values. Linear regression analysis 21 
was used to confirm correlation between hemispheric area loss (dependent variable) and 22 
hippocampal area loss (independent variable). Graphical data are presented as median with 23 
95% confidence intervals (CI) calculated by the exact method (Clopper & Pearson) [27]. A p-24 
value of <0.05 (two-sided) was considered statistically significant. 25 
  26 
 12 
Results 1 
Characterisation of the model 2 
We and others have documented a high degree of variability in the Vannucci model [22]. 3 
Comparing results across laboratories is challenging, and the smallest changes in protocol or 4 
environment can have impact on injury severity. To examine the variability in our laboratory, 5 
we performed a series of experiments with identical hypoxia protocols of 90 min 8% O2, and 6 
compared to previously-performed milder insults of only 50 min at 8%, conducted by the same 7 
researchers (Fig. 3). All experiments were followed by 5 h of NT or HT and 1-week survival 8 
before analysis of relative hemispheric area loss.  9 
50 min of hypoxia induced a median injury degree of 4.1% (CI 0-19) in the first, and 10.4% (CI 10 
2.1-37) in the second run, showing a trend towards statistically different level of severity 11 
(p=0.06). HT treated groups had a median area loss of 4.1% (CI 0-7.8) and 10.9% (CI 7.2-12 
15.4) respectively, thus there was no significant neuroprotection detected with area loss 13 
analysis after these mild insults.  14 
In two experiments using 90 min of hypoxia the median injury degree was 37.5% (CI 3-61.9) 15 
and 45.4% (CI 33.9-52.1) after NT survival. The corresponding HT treated groups had a 16 
reduced median area loss of 17.9% (CI 2.3-45.5) and 35.7% (CI 21.2-47.9) respectively. HT 17 
showed less neuroprotection with increasing injury severity (Fig. 3).  18 
PAM-sensitised HI injury – Left Hemispheric area loss 19 
HT provided significant neuroprotection in Veh-injected rat pups, and reduced brain injury from 20 
57.6% (CI 53-61.8%) in the Veh-NT group to 50.1% (CI 18-54.7%) in the Veh-HT group 21 
(p=0.049). HT was equally neuroprotective in PAM-injected pups, reducing median brain injury 22 
from 60% (CI 43.9-63.5%) in the PAM-NT group, to 47% (CI 33.8-54.8%) in the PAM-HT group 23 
(p=0.03). There was no difference in hemispheric tissue loss between the PAM-sensitised NT 24 
treated pups compared to Veh-injected NT treated pups with Mann-Whitney to group 25 
 13 
comparison (Fig. 4A). Areas of the un-ligated hemispheres were compared across the 4 groups 1 
using the Kruskal-Wallis test. There was no significant difference in tissue loss from the right 2 
hemispheres in this model (p=0.9). Mortality in the PAM-NT group was 6.6%, and 4.5% in the 3 
Veh-NT animals. 4 
PAM-sensitised HI injury – Left Hippocampal area loss  5 
Hippocampal area loss was also significantly reduced in the Veh-HT group with median  6 
43% (CI 26-55%) tissue loss, compared to 59.5% (CI 42.9-64.3%) in the Veh-NT group 7 
(p=0.042) (Fig. 4A). The same was true for the PAM-injected pups, where median 8 
hippocampal area loss was reduced from 61.1% (CI 53-63.5%) in the PAM-NT group, to 9 
38.5% (CI 27-56.3%) in the PAM-HT group (p=0.027).  10 
There was no statistical difference between NT-treated pups pre-treated with Veh 11 
compared to those who received PAM, with respect to both hemispheric area loss (57.6% 12 
vs 59.9%), and hippocampal area loss (59.5% vs 61.1%). Linear regression analysis 13 
showed a significant correlation between hemispheric and hippocampal area loss (R2=0.7-14 
0.9, p<0.0001 for all four groups, B=0.823). 15 
 16 
 17 
 14 
Figure 4. Area loss (%). 1 
A: Aligned dot plot with horizontal lines representing the median. P7 rat pups were injected i.p. 2 
with vehicle (Veh) or PAM3CSK4 (PAM). All pups were subjected to left carotid artery ligation 3 
before 90 min of 8% hypoxia, and 5 hours of normothermia (NT37°C) or hypothermia (HT32°C) 4 
treatment, with 7 days’ survival. HT provided significant reduction in hemispheric (Hem) and 5 
hippocampal (Hip) area loss in both Veh- and PAM-injected groups. *p<0.05.  6 
B: Representative brain slices stained with Haematoxyline&Eosin, demonstrating the severity 7 
of left hemispheric tissue loss. 8 
 9 
PAM-sensitised HI injury - Neuronal Rescue in the CA1 Hippocampal Region 10 
The total number of neurons in three 200x200μm fields of the CA1 region of the left 11 
hippocampus were counted in a subset of animals from all 4 treatment groups (n=10-11 12 
per group) (Fig. 5). The number of remaining hippocampal neurons was similar in PAM-13 
NT animals (4, CI 0-110.5) to the number in Veh-NT animals (1.25, CI 0-53.5). Significant 14 
neuronal rescue was seen in the Veh-HT group (48.5, CI 3-132) compared to Veh-NT 15 
(p=0.03). In the PAM-HT group (74, CI 11-120.5) numbers did not reach statistical 16 
significance due to low numbers, but there was a trend towards neuronal rescue, 17 
compared to PAM-NT animals (p=0.06). The neuron count per three fields correlated 18 
inversely with hemispheric area loss (R2=0.24, p=0.0016). 19 
 20 
 15 
 1 
Figure 5. Neuron count in the hippocampal CA1 region 2 
A: Three non-overlapping regions-of-interest (200 µm2) were analysed from the left 3 
hippocampal CA1-region per brain. Each symbol represents the total number of hippocampal 4 
neurons counted in one animal. Horizontal lines show the median. The neuron count was not 5 
different in PAM3CSK4 (PAM) -injected animals compared to vehicle (Veh) -animals treated 6 
with normothermia (NT37°C). Hypothermia (HT32°C) provided neuronal rescue both in the Veh-7 
group and after PAM sensitisation. *p<0.05. B: Representative images from the left 8 
hippocampal CA1 region are shown from each experimental group (B). Slides were stained 9 
with NeuN (green) and DAPI (blue). Neurons with green cytoplasm (arrows) were rarely seen 10 
in the Veh-NT and PAM-NT groups.  11 
 16 
Discussion 1 
This study demonstrates hypothermic neuroprotection in severe HI brain injury, as well as in 2 
severe HI brain injury with prior PAM exposure.  3 
The relatively low hypothermic neuroprotective effect (13% reduction in hemispheric area 4 
loss, and a 28% reduction of hippocampal tissue) in the non-sensitised group is what we 5 
would expect after such severe injury. We have traditionally seen a 25-50% degree of 6 
neuroprotection in moderate brain injury [5,28]. In the mildest injuries, the method of 7 
hemispheric area loss is unable to identify small changes. HT appears to be neuroprotective 8 
over a continuum of injury severity in this model, and the effect tapers off with increasing 9 
area loss (Fig. 3).  10 
With a median area loss of near 60% in the current study, the injury is defined as severe. 11 
The relation between hypoxia time and area loss severity is not linear, and the variability of 12 
injury induced by the insult is large [22]. When a certain injury severity is reached, a further 13 
duration of the hypoxic insult will not increase injury correspondingly. Therefore, upon 14 
adjusting the model to examine severe injury, the intrahypoxic temperature has been 15 
elevated by one degree Celsius. Previously-published data on the lack of HT neuroprotection 16 
in severe brain injury in the Vannucci model (after 60 and 66% area loss respectively) [4,5], 17 
comes from an experimental design where the hypoxic insult was administered at an 18 
elevated temperature of 37°C rather than the standard 36°C. In addition a longer hypoxia 19 
time was used (150 min vs 90 min). The importance of the intra-hypoxic temperature was 20 
addressed by Busto et al in 1987, demonstrating that even minimal temperature changes will 21 
have impact on injury severity [29]. Northington et al. describe a continuum phenotype of cell 22 
death that varies on a cell-by-cell basis in the neonatal forebrain after an HI insult, and show 23 
how apoptotic cascades are triggered simultaneously with mitochondrial structural and 24 
functional failure. They suggest that the phenotype of cell death is dependent on the energy 25 
available to drive the apoptotic pathways to completion [30]. When a higher intra-ischaemic 26 
 17 
temperature alters the metabolic rate and increases energy demands during the injurious 1 
processes, this leads to further compromise in cellular energy reserves, which would then 2 
shift more cells towards the necrotic side of the cell death spectrum. 3 
By changing the temperature by 1 degree Celsius in our model, although the medians remain 4 
the same, we see a clear reduction in variability of injury within the group, as well as 5 
increased mortality, among those who received the insult at a higher temperature (Fig. 6). 6 
There are no surviving pups with injury in the mild range, and also fewer of those pups with 7 
very severe area loss, probably due to death.  8 
 9 
Figure 6. Different distribution of injury with elevated intrahypoxic temperature.  10 
Horizontal lines represent the median hemispheric area loss, bars show median with 95% 11 
confidence interval. P7 rat pups were subjected to left carotid artery ligation before 90 or 150 12 
minutes of 8% hypoxia, administered at 36°C or 37°C. The left (black) bars display current 13 
data from the Vehicle-Normothermia group (hypoxia administered at 36ºC). The right bars 14 
show unpublished data from our laboratory (M. Thoresen Bristol laboratory), where hypoxia 15 
was administered at 37ºC. Both insults induced a median area loss of around 60%, but with 16 
different distribution and mortality (4.5 vs 28%).  17 
 18 
The proportion of permeable mitochondria is thought to be pivotal with regards to necrotic 1 
cellular death relative to the controlled necroptotic-apoptotic type [31–33], and Hagberg 2 
suggests that mitochondrial permeabilisation would lead to injury beyond the point of no 3 
return [34]. Hua et al. demonstrated reduced number of rat cortical neurons with 4 
mitochondrial injury in culture exposed to hypoxia at 33°C compared to hypoxia at 37°C [35]. 5 
Taken together this suggests that an increased core temperature during the HI insult leads to 6 
more severe mitochondrial injury and thereby more necrotic type cellular death, beyond the 7 
point of hypothermic rescue.  8 
Clinically, elevated intrahypoxic temperature could reflect fever. The strong association 9 
between maternal pyrexia and severe CP was studied before the era when HT became a 10 
treatment option [8]. The most common cause of fever in otherwise healthy adults is viral 11 
infections [36]. In pre-clinical research, in addition to bacterial type pre-sensitisation through 12 
TLR-2 (PAM) or TLR 4 (LPS), pre-sensitisation with Poly I:C (acts through TLR-3 and mimics 13 
a viral infection) prior to an HI insult, also sensitises the immature brain to HI [16,37]. It is 14 
therefore reasonable to hypothesise that any systemic inflammatory activation with an 15 
elevated core temperature during an HI insult, could lead to a more severe and definite type 16 
of neuronal injury, with less potency for hypothermic rescue. The lack of hypothermic 17 
neuroprotection in a setting of elevated intrahypoxic temperature was already shown by 18 
Yager et al in 1995 [24]. Furthermore, post-HI hyperthermia increased morbidity and 19 
mortality in neonatal rat pups compared to normothermia treatment [38], supporting the role 20 
of temperature on the extent of HI damage. The hypothesis poses the question of whether 21 
strictly controlling maternal core temperature at normothermia (37°C) prior to and during 22 
labour would improve neonatal outcome, and/or reduce the incidence of HIE. This remains to 23 
be investigated. 24 
 25 
In this study, mortality is low, similarly to that seen in the previous PAM-sensitised 26 
experiments with only 50 min of hypoxia [17]. When inflammatory activation was induced by 27 
 19 
LPS imitating a gram-negative type sepsis prior to the HI insult, mortality was very high (> 1 
40%) after only 50 min of hypoxia [16]. Eklind et al reported in 2001 how LPS-treated pups 2 
showed increasing mortality with increasing length of hypoxia, starting already at 20 min [10]. 3 
Administering as much as 90 min of hypoxia to P7 rat pups pre-treated with LPS was not 4 
possible due to the high mortality at 50 min. This distinct difference between the two models, 5 
as well as the difference in susceptibility to hypothermic neuroprotection (Fig. 1) [16], is in 6 
line with other discrepancies between LPS- and PAM-triggered inflammation and how they 7 
affect the immature brain even without the HI insult [21]. LPS induced significant brain 8 
apoptosis, poor weight gain, and immediate loss of core temperature (median 31.2ºC). PAM 9 
did neither, and the pups remained at normothermia. The effect of the studied intervention on 10 
thermoregulation is critical in pre-clinical models of neonatal HI and neuroprotection [39]. The 11 
profound mortality among LPS-sensitised pups might partly be explained by the temperature 12 
drop that LPS induces prior to the HI insult [21]. This means that during the insult, we impose 13 
a much greater temperature elevation in LPS-sensitised animals than we do in PAM-14 
sensitised animals, and intrahypoxic temperature is relatively higher for the LPS pups. This 15 
partly makes them similar to the pups in the previous experiments of severe HI injury, where 16 
the intrahypoxic temperature was elevated. The mortality was high, and HT was not 17 
neuroprotective.  18 
 19 
PAM exposed pups do not have a higher level of injury than the control group in the current 20 
study. However, we have robustly shown that PAM does sensitise the immature brain to a 21 
mild HI insult, and increases area loss from 10% in the vehicle group to 36% in the PAM 22 
sensitised group [17]. Furthermore, PAM is a highly stable synthetically manufactured 23 
agonist to TLR2. PAM sensitisation reduced the threshold for cellular injury after a mild insult, 24 
but our current results show that with longer hypoxia time and a more severe insult, the 25 
vulnerability induced by PAM is no longer visible. This phenomenon has previously been 26 
shown after LPS pre-treatment, however they still displayed increased mortality [10]. In the 27 
 20 
model of with PAM exposure, in clear contrast to after LPS sensitisation, the injurious effect 1 
of the HI insult appears to be more significant to the outcome than the inflammatory pre-2 
sensitisation, and the damage induced by the inflammatory response and HI are no longer 3 
additive.  4 
We have not investigated white matter injury, a limitation to a study on inflammatory-evoked 5 
injury to the immature brain. Although also a part of term HI injury pattern, white matter injury 6 
is more of a focus in injury to the preterm [9], while this being a model of late preterm to term 7 
equivalent brain maturity. Additionally, the injury severity in our model makes investigations 8 
on white matter challenging, as there is little remaining tissue on the injured side (Fig.4B). 9 
HT is neuroprotective in the current study, with a 22% and 37% reduction of hemispheric and 10 
hippocampal area loss respectively in the PAM-sensitised group. A plausible hypothesis 11 
might be that the inflammatory activation in the absence of marked temperature changes 12 
lowers the threshold to cellular injury from an HI insult, without leading to neuronal necrosis, 13 
and thereby maintaining susceptibility to hypothermic rescue. The increased rate of infection 14 
(6-13%) among HIE neonates, compared to 0.5-1% in the general population supports the 15 
theory of elevated susceptibility to HI [40,41]. HT reduces mortality and severe neurological 16 
morbidity in asphyxiated neonates, even though the investigated cohorts include infants with 17 
severe encephalopathy of HI origin both with and without infectious pre-sensitisation [1,42].  18 
With these data we conclude that there is no one level of HI-induced area loss where HT is 19 
not a beneficial therapy in this model. Rather there is a continuum along which HT reduces 20 
permanent neuronal injury. PAM exposure prior to a moderate HI insult did not sensitise to 21 
increased brain injury severity. Based on our results from PAM-sensitised injury with a milder 22 
HI insult, in combination with these current data, we suggest that inflammatory exposure 23 
through the gram-positive route is not likely to negate hypothermic neuroprotection at any 24 
level of severity in the term neonate. 25 
 21 
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